Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 9/20 | 0.56 |
| ▸ | AR | P10275 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | DAO | P14920 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MPO | P05164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16429432 | 0.79 | CYP1A2 (0.50) | AKR1B1KDM4ECYP1A2 | |
| SCHEMBL5374414 | 0.77 | CYP3A4 (0.67) | AKR1B1ARKDM4EALDH1A1DAO | |
| SCHEMBL15269519 | 0.77 | HPGD (0.49) | AKR1B1KDM4EALDH1A1 | |
| SCHEMBL7276901 | 0.76 | AR (0.55) | AR | |
| SCHEMBL3215294 | 0.76 | AKR1B1 (0.43) | AKR1B1ARKDM4ECYP1A2 | |
| SCHEMBL5351260 | 0.75 | AKR1B1 (0.51) | AKR1B1ARKDM4EALDH1A1DAO | |
| SCHEMBL14719562 | 0.75 | AR (0.54) | AKR1B1ARKDM4EALDH1A1DAO | |
| SCHEMBL14232746 | 0.74 | AR (0.44) | AKR1B1ARKDM4EALDH1A1DAO | |
| SCHEMBL2928229 | 0.73 | MPO (0.47) | AKR1B1ARKDM4EALDH1A1DAO | |
| SCHEMBL6238212 | 0.72 | AKR1B1 (1.00) | AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1136197-C | Novel pyridajinone derivatives | - | 2004-01-28 | — | — | CN | disclosed |
| EP-0810218-B1 | 6-Benzyl-2H-pyridazin-3-one derivatives,their preparation and their use as inhibitors of prostaglandin G/H synthase I and II (COX I and COX II) | HOFFMANN LA ROCHE (CH) | 2002-12-04 | — | — | EP | disclosed |
| US-5886178-A | ADMINISTERING OF A PROSTAGLANDIN G/H SYNTHASE INHIBITOR TO A PATIENT TO TREAT INFLAMMATORY OR AUTOIMMUNE DISEASES | SYNTEX (U.S.A.) INC. (US) | 1999-03-23 | — | — | US | disclosed |
| CN-1169426-A | Novel pyridajinone derivatives | HOFFMANN LA ROCHE (CH) | 1998-01-07 | — | — | CN | disclosed |
| EP-0810218-A1 | 6-Benzyl-2H-pyridazin-3-one derivatives,their preparation and their use as inhibitors of prostaglandin G/H synthase I and II (COX I and COX II) | F. HOFFMANN-LA ROCHE AG (CH) | 1997-12-03 | — | — | EP | disclosed |